POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy

QR Code

POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yan‐Xing Chen, Zi‐Xian Wang, Shu‐Qiang Yuan, Teng‐Jia Jiang, You‐Sheng Huang, Rui‐Hua Xu, Feng Wang, Qi Zhao
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/b915738d37a5444facd0e60cedcf9b20
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort
par: Nikhat Khan, et autres
Publié: (2017)

A domain in human EXOG converts apoptotic endonuclease to DNA-repair exonuclease
par: Michal R. Szymanski, et autres
Publié: (2017)

Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors
par: Hee Sang Hwang, et autres
Publié: (2021)

Indicators of responsiveness to immune checkpoint inhibitors
par: Bradley D. Shields, et autres
Publié: (2017)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
par: Zheng-Hang Wang, et autres
Publié: (2018)

Shared active site architecture between archaeal PolD and multi-subunit RNA polymerases revealed by X-ray crystallography
par: Ludovic Sauguet, et autres
Publié: (2016)

Managing cardiotoxicity associated with immune checkpoint inhibitors
par: Sireesha Upadhrasta, et autres
Publié: (2019)

Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
Publié: (2021)

Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
par: Di Wang, et autres
Publié: (2021)

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
par: Claire Vanpouille-Box, et autres
Publié: (2017)

Dynamic coordination of two-metal-ions orchestrates λ-exonuclease catalysis
par: Wonseok Hwang, et autres
Publié: (2018)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
par: Ben‐Yuan Jiang, et autres
Publié: (2021)

Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
par: Can Öztürk, et autres
Publié: (2021)

A decade of immune-checkpoint inhibitors in cancer therapy
par: Caroline Robert
Publié: (2020)

The biogeographic differentiation of algal microbiomes in the upper ocean from pole to pole
par: Kara Martin, et autres
Publié: (2021)

Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
par: Pan Shen, et autres
Publié: (2021)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
par: Zou W, et autres
Publié: (2021)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
par: Nicola Personeni, et autres
Publié: (2021)

Acute kidney injury in patients treated with immune checkpoint inhibitors
par: Enriqueta Felip, et autres
Publié: (2021)

Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer
par: Zhenghang Wang, et autres
Publié: (2021)

MutL sliding clamps coordinate exonuclease-independent Escherichia coli mismatch repair
par: Jiaquan Liu, et autres
Publié: (2019)

The exonuclease Xrn1 activates transcription and translation of mRNAs encoding membrane proteins
par: Bernat Blasco-Moreno, et autres
Publié: (2019)

Non-permanent Pole-to-pole Fault Restoration Strategy for Flexible DC Distribution Network
par: Zainan Li, et autres
Publié: (2021)

NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors
par: Romel Somwar, et autres
Publié: (2020)

Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective Study
par: Xiaozhun Huang, et autres
Publié: (2021)

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
par: James Harber, et autres
Publié: (2021)

The roles of exosomal immune checkpoint proteins in tumors
par: Cheng Xing, et autres
Publié: (2021)

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
par: Andrew Haydon, et autres
Publié: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
par: Zoe Apalla, et autres
Publié: (2021)

Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy
par: Selina K. Wong, et autres
Publié: (2021)

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
par: Yingyan Yu
Publié: (2021)

Progress of Immune Checkpoint Inhibitors  in the Treatment of Advanced Pulmonary Neuroendocrine Tumors
par: Haoqing CHEN, et autres
Publié: (2021)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
par: Linda Wu, et autres
Publié: (2021)

Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study
par: Anne R Bass, et autres
Publié: (2021)

Clinical Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors on NSCLC
par: ZHU Kuikui, et autres
Publié: (2021)

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
par: Kimberly M. Burcher, et autres
Publié: (2021)

A senataxin-associated exonuclease SAN1 is required for resistance to DNA interstrand cross-links
par: Alex M. Andrews, et autres
Publié: (2018)

Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model
par: Chiao-Fang Teng, et autres
Publié: (2020)

Effect of pole size on preservative penetration and retention in air-dried ugandan grown eucalypt utility poles
par: Mugabi,Paul, et autres
Publié: (2018)

Highly Sensitive and Selective Copper (II)-Catalyzed Dual-DNAzyme Colorimetric Biosensor Based on Exonuclease III-Mediated Cyclical Assembly
par: Baiqiang Zhai, et autres
Publié: (2021)